Dr. En-Bo Wu is an Attending Physician in Anesthesiology at China Medical University Hospital in Taichung, a position he has held since July 2024. Previously, he served as an Attending Physician in the Department of Anesthesiology at Kaohsiung Chang Gung Memorial Hospital (2021–2024). A graduate of Kaohsiung Medical University, he focuses on advancing perioperative safety, optimizing neuromuscular blockade, and developing opioid-sparing strategies. His research explores rocuronium, sugammadex, and intravenous magnesium to mitigate remifentanil-induced hyperalgesia, reflecting his commitment to evidence-based analgesic approaches. Dr. Wu has authored numerous peer-reviewed articles in journals such as Bioengineering, the British Journal of Anaesthesia, the Journal of Pain Research, and Pharmaceuticals, advocating enhanced recovery pathways and personalized medicine. He regularly collaborates with interdisciplinary teams, employing refined monitoring techniques and risk factor analysis to improve patient outcomes and reduce complications. Alongside his clinical responsibilities, Dr. Wu is passionate about mentorship, guiding younger colleagues in anesthesiology while continuously expanding his own expertise. By integrating academic rigor and practical insights, he endeavors to optimize perioperative care and promote patient-centric treatment across diverse surgical specialties.